TESTBANK nn
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
nn nn nn nn nn nn nn
Author:Teri Moser Woo and Wendy L. Wright
nn nn nn nn nn nn nn
, TABLE OF CONTENT nn nn
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber............................................................................ 4
nn nn nn nn nn nn nn nn nn nn
Chapter 2. Review of Basic Principles of Pharmacology .......................................................................................... 5
nn nn nn nn nn nn nn
Chapter 3. Rational Drug Selection ....................................................................................................................... 11
nn nn nn nn
Chapter 4. Legal and Professional Issues in Prescribing ......................................................................................... 14
nn nn nn nn nn nn nn
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
nn nn nn nn
Chapter 6. An Introduction to Pharmacogenomics................................................................................................. 19
nn nn nn nn nn
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................ 22
nn nn nn nn
Chapter 8. Herbal Therapies.................................................................................................................................. 28
nn nn nn
Chapter 9. Cannabis.............................................................................................................................................. 31
nn nn
Chapter 10. Pharmacoeconomics .......................................................................................................................... 35
nn nn
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
nn nn nn nn nn nn nn
Chapter 12. Drugs Affecting the Central Nervous System...................................................................................... 45
nn nn nn nn nn nn nn
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems...................................................................... 53
nn nn nn nn nn nn nn nn
Chapter 14. Drugs Affecting the Respiratory System............................................................................................. 61
nn nn nn nn nn nn
Chapter 15. Drugs Affecting the Hematological System ........................................................................................ 65
nn nn nn nn nn nn
Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
nn nn nn nn nn nn nn nn nn
Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
nn nn nn nn nn nn nn
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
nn nn nn nn nn nn
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesand Antidiabetic Drugs .......................... 80
n n nn nn nn n nn nn nn nn nn
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................... 83
nn nn nn nn nn nn nn nn nn nn nn
Chapter 21. Drugs Affecting the Reproductive System .......................................................................................... 86
nn nn nn nn nn nn
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................. 92
nn nn nn nn nn nn nn
Chapter 23. Drugs Affecting the Integumentary System ........................................................................................ 96
nn nn nn nn nn nn
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................... 101
nn nn nn nn nn nn nn
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections.............................................................. 105
nn nn nn nn nn nn nn nn nn nn
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................... 108
nn nn nn nn nn nn nn
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
nn nn nn nn nn nn nn nn nn
Chapter 28. Anemia ............................................................................................................................................ 113
nn nn
Chapter 29. Anxiety and Depression ................................................................................................................... 116
nn nn nn nn
Chapter 30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
nn nn nn nn
Chapter 31. Asthma and Allergy ......................................................................................................................... 122
nn nn nn nn
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
nn nn nn nn nn
Chapter 33. Contraception .................................................................................................................................. 127
nn nn
Chapter 34. COVID-19: Acute and Chronic ........................................................................................................ 130
nn nn nn nn nn
Chapter 35. Dermatological Conditions .............................................................................................................. 134
nn nn nn
Chapter 36. Diabetes Management ..................................................................................................................... 138
nn nn nn
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
nn nn nn nn nn nn nn
Chapter 38. Headaches ....................................................................................................................................... 149
nn nn
Chapter 39. Heart Failure .................................................................................................................................... 153
nn nn nn
Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
nn nn nn nn nn nn nn
Chapter 41. Menopausal Hormone Therapy ........................................................................................................ 161
nn nn nn nn
,Chapter 42. Hyperlipidemia................................................................................................................................ 164
nn nn
Chapter 43. Hypertension ................................................................................................................................... 169
nn nn
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................. 174
nn nn nn nn
Chapter 45. Obesity ............................................................................................................................................ 177
nn nn
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
nn nn nn nn nn nn nn
Chapter 47. Pneumonia....................................................................................................................................... 185
nn nn
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................... 187
nn nn nn nn nn nn
Chapter 49. Substance Use Disorders .................................................................................................................. 190
nn nn nn nn
Chapter 50. Tuberculosis .................................................................................................................................... 195
nn nn
Chapter51.UpperRespiratoryTract Infection, Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa .................. 197
n n n nn nn nn nn n n nn nn nn
Chapter 52. Urinary Tract Infections ................................................................................................................... 200
nn nn nn nn
Chapter 53. Women as Patients ........................................................................................................................... 203
nn nn nn nn
Chapter 54. Men as Patients ................................................................................................................................ 207
nn nn nn nn
Chapter 55. Pediatric Patients ............................................................................................................................. 209
nn nn nn
Chapter 57. Geriatric Patients ............................................................................................................................. 213
nn nn nn
, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e n n nn nn Ch01
Chapter1.The Roleof the Advanced PracticeNurse as Prescriber
nn nn nn nn nn nn nn nn nn nn
MULTIPLE CHOICE nn
1. Nurse practitioner prescriptive authority is regulated by:
nn nn nn nn nn nn
A. The National Council of State Boards ofNursing nn nn nn nn nn nn nn
B. The U.S. Drug Enforcement Administration nn nn nn nn
C. The State Board of Nursing for each state nn nn nn nn nn nn nn
D. The State Board of Pharmacy nn nn nn nn
ANS: n n C PTS: n n n n 1
2. Thebenefitstothepatientofhaving anadvanced practice registerednurse(APRN)prescriber
n nn nn n nn n nn nn nn nn nn nn n
nn include:
A. Nursesknowmoreabout pharmacologythanotherprescribersbecausetheytakeit both
n n nn nn nn n nn n n nn n nn
in their basic nursing program and in their APRN program.
nn nn nn nn nn nn nn nn nn nn
B. Nurses careforthepatientfroma holistic approach and includethepatient in
nn nn nn n nn nn nn nn nn nn n n nn
decision-making regarding their care.
nn nn nn nn
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
nn nn nn nn nn nn nn nn nn n
D. APRNs areabletoprescribeindependentlyinallstates,whereas aphysician’snn n n n n n nn n n nn n
assistant needs to have a physician supervising their practice.
nn nn nn nn nn nn nn nn nn
ANS: n n B PTS: n n n n 1
3. Clinical judgment in prescribing includes: nn nn nn nn
A. Factoring in the cost to the patient of the medication prescribed nn nn nn nn nn nn nn nn nn nn
B. Always prescribing the newest medication available for the diseaseprocess nn nn nn nn nn nn nn nn n
C. Handing out drug samples to poor patients nn nn nn nn nn nn
D. Prescribing all generic medications to cutcosts nn nn nn nn nn n
ANS: n n A PTS: n n n n 1
4. The process for choosing an effective drug for a disorderincludes:
nn nn nn nn nn nn nn nn nn n
A. Asking the patient what drug they think would work best for them nn nn nn nn nn nn nn nn nn nn nn
B. Consulting nationally recognized guidelines for diseasemanagement nn nn nn nn nn n
C. Prescribingmedications thatare available as samples beforewriting a prescription nn nn nn nn nn nn nn nn nn nn
D. Following U.S. Drug Enforcement Administration guidelines forprescribing nn nn nn nn nn nn n
ANS: n n B PTS: n n n n 1
5. Nonintentional nonadherence of drug therapy may occur due to: nn nn nn nn nn nn nn nn
A. Belief that medication does not work nn nn nn nn nn
B. Adverse drug reactions nn nn
C. Chronic conditions that require dailytherapy nn nn nn nn n
D. Forgetfulness ordistraction nn n
ANS: n n D PTS: n n n n 1
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
nn nn nn nn nn nn nn
Author:Teri Moser Woo and Wendy L. Wright
nn nn nn nn nn nn nn
, TABLE OF CONTENT nn nn
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber............................................................................ 4
nn nn nn nn nn nn nn nn nn nn
Chapter 2. Review of Basic Principles of Pharmacology .......................................................................................... 5
nn nn nn nn nn nn nn
Chapter 3. Rational Drug Selection ....................................................................................................................... 11
nn nn nn nn
Chapter 4. Legal and Professional Issues in Prescribing ......................................................................................... 14
nn nn nn nn nn nn nn
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
nn nn nn nn
Chapter 6. An Introduction to Pharmacogenomics................................................................................................. 19
nn nn nn nn nn
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................ 22
nn nn nn nn
Chapter 8. Herbal Therapies.................................................................................................................................. 28
nn nn nn
Chapter 9. Cannabis.............................................................................................................................................. 31
nn nn
Chapter 10. Pharmacoeconomics .......................................................................................................................... 35
nn nn
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
nn nn nn nn nn nn nn
Chapter 12. Drugs Affecting the Central Nervous System...................................................................................... 45
nn nn nn nn nn nn nn
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems...................................................................... 53
nn nn nn nn nn nn nn nn
Chapter 14. Drugs Affecting the Respiratory System............................................................................................. 61
nn nn nn nn nn nn
Chapter 15. Drugs Affecting the Hematological System ........................................................................................ 65
nn nn nn nn nn nn
Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
nn nn nn nn nn nn nn nn nn
Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
nn nn nn nn nn nn nn
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
nn nn nn nn nn nn
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesand Antidiabetic Drugs .......................... 80
n n nn nn nn n nn nn nn nn nn
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................... 83
nn nn nn nn nn nn nn nn nn nn nn
Chapter 21. Drugs Affecting the Reproductive System .......................................................................................... 86
nn nn nn nn nn nn
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................. 92
nn nn nn nn nn nn nn
Chapter 23. Drugs Affecting the Integumentary System ........................................................................................ 96
nn nn nn nn nn nn
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................... 101
nn nn nn nn nn nn nn
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections.............................................................. 105
nn nn nn nn nn nn nn nn nn nn
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................... 108
nn nn nn nn nn nn nn
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
nn nn nn nn nn nn nn nn nn
Chapter 28. Anemia ............................................................................................................................................ 113
nn nn
Chapter 29. Anxiety and Depression ................................................................................................................... 116
nn nn nn nn
Chapter 30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
nn nn nn nn
Chapter 31. Asthma and Allergy ......................................................................................................................... 122
nn nn nn nn
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
nn nn nn nn nn
Chapter 33. Contraception .................................................................................................................................. 127
nn nn
Chapter 34. COVID-19: Acute and Chronic ........................................................................................................ 130
nn nn nn nn nn
Chapter 35. Dermatological Conditions .............................................................................................................. 134
nn nn nn
Chapter 36. Diabetes Management ..................................................................................................................... 138
nn nn nn
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
nn nn nn nn nn nn nn
Chapter 38. Headaches ....................................................................................................................................... 149
nn nn
Chapter 39. Heart Failure .................................................................................................................................... 153
nn nn nn
Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
nn nn nn nn nn nn nn
Chapter 41. Menopausal Hormone Therapy ........................................................................................................ 161
nn nn nn nn
,Chapter 42. Hyperlipidemia................................................................................................................................ 164
nn nn
Chapter 43. Hypertension ................................................................................................................................... 169
nn nn
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................. 174
nn nn nn nn
Chapter 45. Obesity ............................................................................................................................................ 177
nn nn
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
nn nn nn nn nn nn nn
Chapter 47. Pneumonia....................................................................................................................................... 185
nn nn
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................... 187
nn nn nn nn nn nn
Chapter 49. Substance Use Disorders .................................................................................................................. 190
nn nn nn nn
Chapter 50. Tuberculosis .................................................................................................................................... 195
nn nn
Chapter51.UpperRespiratoryTract Infection, Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa .................. 197
n n n nn nn nn nn n n nn nn nn
Chapter 52. Urinary Tract Infections ................................................................................................................... 200
nn nn nn nn
Chapter 53. Women as Patients ........................................................................................................................... 203
nn nn nn nn
Chapter 54. Men as Patients ................................................................................................................................ 207
nn nn nn nn
Chapter 55. Pediatric Patients ............................................................................................................................. 209
nn nn nn
Chapter 57. Geriatric Patients ............................................................................................................................. 213
nn nn nn
, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e n n nn nn Ch01
Chapter1.The Roleof the Advanced PracticeNurse as Prescriber
nn nn nn nn nn nn nn nn nn nn
MULTIPLE CHOICE nn
1. Nurse practitioner prescriptive authority is regulated by:
nn nn nn nn nn nn
A. The National Council of State Boards ofNursing nn nn nn nn nn nn nn
B. The U.S. Drug Enforcement Administration nn nn nn nn
C. The State Board of Nursing for each state nn nn nn nn nn nn nn
D. The State Board of Pharmacy nn nn nn nn
ANS: n n C PTS: n n n n 1
2. Thebenefitstothepatientofhaving anadvanced practice registerednurse(APRN)prescriber
n nn nn n nn n nn nn nn nn nn nn n
nn include:
A. Nursesknowmoreabout pharmacologythanotherprescribersbecausetheytakeit both
n n nn nn nn n nn n n nn n nn
in their basic nursing program and in their APRN program.
nn nn nn nn nn nn nn nn nn nn
B. Nurses careforthepatientfroma holistic approach and includethepatient in
nn nn nn n nn nn nn nn nn nn n n nn
decision-making regarding their care.
nn nn nn nn
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
nn nn nn nn nn nn nn nn nn n
D. APRNs areabletoprescribeindependentlyinallstates,whereas aphysician’snn n n n n n nn n n nn n
assistant needs to have a physician supervising their practice.
nn nn nn nn nn nn nn nn nn
ANS: n n B PTS: n n n n 1
3. Clinical judgment in prescribing includes: nn nn nn nn
A. Factoring in the cost to the patient of the medication prescribed nn nn nn nn nn nn nn nn nn nn
B. Always prescribing the newest medication available for the diseaseprocess nn nn nn nn nn nn nn nn n
C. Handing out drug samples to poor patients nn nn nn nn nn nn
D. Prescribing all generic medications to cutcosts nn nn nn nn nn n
ANS: n n A PTS: n n n n 1
4. The process for choosing an effective drug for a disorderincludes:
nn nn nn nn nn nn nn nn nn n
A. Asking the patient what drug they think would work best for them nn nn nn nn nn nn nn nn nn nn nn
B. Consulting nationally recognized guidelines for diseasemanagement nn nn nn nn nn n
C. Prescribingmedications thatare available as samples beforewriting a prescription nn nn nn nn nn nn nn nn nn nn
D. Following U.S. Drug Enforcement Administration guidelines forprescribing nn nn nn nn nn nn n
ANS: n n B PTS: n n n n 1
5. Nonintentional nonadherence of drug therapy may occur due to: nn nn nn nn nn nn nn nn
A. Belief that medication does not work nn nn nn nn nn
B. Adverse drug reactions nn nn
C. Chronic conditions that require dailytherapy nn nn nn nn n
D. Forgetfulness ordistraction nn n
ANS: n n D PTS: n n n n 1
